Adropin Improves Radiation‐Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway
Open Access
- 29 June 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 8230214
Abstract
Mediastinal cancer radiotherapy exposes the heart and causes myocardial injury. It is of utmost importance to identify effective prevention and treatment targets. In this study, the regulatory role of adropin (Ad) in radiation‐induced myocardial injury (RIMI) was explored in mice. After C57BL/6 mice were administered E0771 cells and received radiotherapy, the effects of exogenous Ad intervention on myocardial fibrosis, apoptosis, microvessel density, oxidative stress, and protein expression levels were observed. The results showed that exogenous Ad effectively improved cardiac function, suppressed oxidative stress, inhibited myocardial fibrosis, reduced myocardial apoptosis, and promoted microangiogenesis in RIMI mice. Ad also downregulated the expression levels of transforming growth factor β1 (TGF‐β1), NADPH oxidase 4 (NOX4), and cleaved caspase 3 and upregulated the expression of phosphor‐endothelial nitric oxide synthase (p‐eNOS). However, the above‐mentioned effects of Ad were significantly reversed in Ad-/- mice. Radiotherapy resulted in the downregulation of phosphor‐vascular endothelial growth factor receptor (p‐VEGFR2) and p‐Akt in myocardial tissue, which were upregulated by Ad. However, after targeted inhibition of VEGFR2 with apatinib, the effect of Ad on improving RIMI was significantly reversed. Taken together, exogenous Ad significantly ameliorated RIMI by reducing oxidative stress, promoting microangiogenesis, and inhibiting myocardial fibrosis and apoptosis. The underlying molecular mechanism involved may be elucidated by activation of the VEGFR2/PI3K/Akt pathway.Keywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20202ACBL206004)
- National Natural Science Foundation of China (81860058)
This publication has 29 references indexed in Scilit:
- Endothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathwayMolecular Brain, 2016
- A novel peptide adropin in cardiovascular diseasesClinica Chimica Acta, 2016
- Mechanisms of cardiac radiation injury and potential preventive approachesCanadian Journal of Physiology and Pharmacology, 2015
- Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistanceMolecular Metabolism, 2015
- Regulation of Substrate Oxidation Preferences in Muscle by the Peptide Hormone AdropinDiabetes, 2014
- Adropin Deficiency Is Associated With Increased Adiposity and Insulin ResistanceObesity, 2012
- Adropin Is a Novel Regulator of Endothelial FunctionCirculation, 2010
- Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid MetabolismCell Metabolism, 2008
- VEGF Signaling Through NADPH Oxidase-Derived ROSAntioxidants & Redox Signaling, 2007
- VEGF Receptor Signal TransductionScience's STKE, 2001